SIRPA and cancer: Thus, it is believed to be important to block CD47–SIRPα interactions removes this inhibitory checkpoint signal augmenting the macrophage-mediated clearance of cancer cells (245), inducing DCs endocytosis and activation with the consequent T-cell mediated tumor clearance (243, 246, 247) (Figure 1B).